Danimer Scientific (DNMR) is set to be delisted by the New York Stock Exchange for failing to meet the requirement that listed companies maintain an average global market capitalization of at least $15 million, the exchange said late Monday.
Trading in the company's class A stock has been suspended as delisting proceedings commence, the NYSE said.
"The company has a right to a review of this determination by a committee of the board of directors of the exchange," the NYSE said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.